DQA is an inhibitor of apoptotic proteins that can directly inhibit the activity of caspases, regulate apoptosis through multiple pathways, and promote the degradation of Bcl-2 as an E3 ligase, thereby exerting anti-tumor effects. Here, BCL2 is linked to neoplasm.